Literature DB >> 16518346

The MCP-1/CCR2 system has direct proinflammatory effects in human mesangial cells.

S Giunti1, S Pinach, L Arnaldi, G Viberti, P C Perin, G Camussi, G Gruden.   

Abstract

Both inflammatory and haemodynamic factors have been implicated in the pathogenesis of diabetic and other progressive glomerulopathies. Mesangial cell exposure to mechanical stretch induces both intercellular adhesion molecule 1 (ICAM-1) and monocyte chemoattractant protein-1 (MCP-1) expression. CC Chemokine receptor 2 (CCR2), the cognate MCP-1 receptor, has been recently demonstrated in human mesangial cells (HMCs). We tested whether MCP-1 binding to CCR2 affects ICAM-1 expression in HMCs and, secondly, if stretch-induced ICAM-1 is mediated by MCP-1 via an autocrine mechanism. Serum-deprived HMCs were exposed to either rh-MCP-1 (0.1-1-10-50-100 ng/ml) or mechanical stretch in the presence and in the absence of RS102895, a specific CCR2 inhibitor. ICAM-1 expression was assessed both by immunofluorescence and cytofluorimetry. Monocyte-HMC interaction was tested by adhesion assay. CCR2 expression was studied by reverse transcriptase-polymerase chain reaction, immunoblotting, and flow cytometry. HMCs exposure to rh-MCP-1 induced a significant twofold increase in ICAM-1 expression at 24 h, leading to enhanced monocyte adhesion. This effect occurred via the CCR2 receptor as CCR2 was expressed in HMCs and CCR2 blockade prevented ICAM-1 upregulation. Stretch-induced ICAM-1 expression was not altered by CCR2 blockade and stretch significantly reduced CCR2 mRNA and protein expression via an MCP-1-independent mechanism. In conclusion, stretch and MCP-1 independently induce ICAM-1 expression in HMCs. Stretch-induced CCR2 downregulation may favour MCP-1 paracrine activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16518346     DOI: 10.1038/sj.ki.5000197

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  26 in total

1.  Cytokines in chronic kidney disease: potential link of MCP-1 and dyslipidemia in glomerular diseases.

Authors:  Heloisa Reniers Vianna; Cristina Maria Bouissou M Soares; Katia Daniela Silveira; Gustavo Siqueira Elmiro; Philipe Melgaço Mendes; Marcelo de Sousa Tavares; Mauro Martins Teixeira; Débora Marques Miranda; Ana Cristina Simões E Silva
Journal:  Pediatr Nephrol       Date:  2012-11-18       Impact factor: 3.714

Review 2.  Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment.

Authors:  Federica Barutta; Graziella Bruno; Serena Grimaldi; Gabriella Gruden
Journal:  Endocrine       Date:  2014-10-02       Impact factor: 3.633

3.  Sequential Activation of Two Pathogen-Sensing Pathways Required for Type I Interferon Expression and Resistance to an Acute DNA Virus Infection.

Authors:  Ren-Huan Xu; Eric B Wong; Daniel Rubio; Felicia Roscoe; Xueying Ma; Savita Nair; Sanda Remakus; Reto Schwendener; Shinu John; Mark Shlomchik; Luis J Sigal
Journal:  Immunity       Date:  2015-12-15       Impact factor: 31.745

4.  Implications of immune system in stroke for novel therapeutic approaches.

Authors:  Aaron A Hall; Keith R Pennypacker
Journal:  Transl Stroke Res       Date:  2010-01-13       Impact factor: 6.829

5.  Mechanical strain activates a program of genes functionally involved in paracrine signaling of angiogenesis.

Authors:  Ru Yang; Jawaria Amir; Haibo Liu; Brahim Chaqour
Journal:  Physiol Genomics       Date:  2008-10-14       Impact factor: 3.107

6.  Selective CCR2-targeted macrophage depletion ameliorates experimental mesangioproliferative glomerulonephritis.

Authors:  L M McIntosh; J L Barnes; V L Barnes; J R McDonald
Journal:  Clin Exp Immunol       Date:  2008-11-25       Impact factor: 4.330

7.  Substance P induces inflammatory responses involving NF-κB in genetically diabetic mice skin fibroblasts co-cultured with macrophages.

Authors:  Tao Ni; Yushu Liu; Yinbo Peng; Ming Li; Yong Fang; Min Yao
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

8.  Nf1+/- monocytes/macrophages induce neointima formation via CCR2 activation.

Authors:  Waylan K Bessler; Grace Kim; Farlyn Z Hudson; Julie A Mund; Raghuveer Mali; Keshav Menon; Reuben Kapur; D Wade Clapp; David A Ingram; Brian K Stansfield
Journal:  Hum Mol Genet       Date:  2016-01-05       Impact factor: 6.150

9.  Monocyte chemoattractant protein-1 has prosclerotic effects both in a mouse model of experimental diabetes and in vitro in human mesangial cells.

Authors:  S Giunti; G H Tesch; S Pinach; D J Burt; M E Cooper; P Cavallo-Perin; G Camussi; G Gruden
Journal:  Diabetologia       Date:  2007-10-30       Impact factor: 10.122

10.  Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes.

Authors:  Elena Tarabra; Sara Giunti; Federica Barutta; Gennaro Salvidio; Davina Burt; Giacomo Deferrari; Roberto Gambino; Daniela Vergola; Silvia Pinach; Paolo Cavallo Perin; Giovanni Camussi; Gabriella Gruden
Journal:  Diabetes       Date:  2009-07-08       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.